SpringWorks Therapeutics Announces PDUFA Date Extension for Nirogacestat NDA

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review New PDUFA Date Set to November 27, 2023 STAMFORD, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news